Lensar Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Lensar Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010907
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers various technologies such as LENSAR laser system, augmented reality and smart corneal incisions. Lensar’s laser system fs 3D (LLS-fs 3D) is used during cataract surgery for removal of the crystalline lens. The company’s augmented reality, a reconstructed 3-D imaging, measurement and guidance system provides high-resolution ocular images in a single scan. It also provides practice support and clinical training services. Lensar is headquartered in Orlando, Florida, the US.

Lensar Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lensar Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lensar Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lensar Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lensar Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lensar Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 10
LensAR Raises USD8 Million in Venture Financing 11
LensAR Raises US$10 Million In Venture Financing 12
LensAR Raises US$17.4 Million In Venture Financing 13
LensAR Raises US$5 Million In Venture Financing 14
LensAR Raises US$24 Million In Series F Financing Round 15
LensAR Secures US$1.4 Million In Venture Financing 16
LensAR Secures US$5 Million In Venture Financing 17
LensAR Secures US$2 Million In Financing Round 18
Private Equity 19
LensAR Completes US$27 Million In Private Equity Financing 19
Acquisition 20
Alphaeon Acquires LENSAR for USD59 Million 20
Topcon Europe Medical Invests US$4 Million In LensAR 21
Lensar Inc – Key Competitors 22
Lensar Inc – Key Employees 23
Lensar Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Nov 08, 2017: Ophthalmic Industry Leader William J. Link, Ph.D., Joins LENSAR Board of Directors as Chairman 25
Legal and Regulatory 26
Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Lensar Inc, Medical Equipment, Key Facts 2
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Lensar Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lensar Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lensar Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lensar Inc, Deals By Market, 2011 to YTD 2017 8
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 10
LensAR Raises USD8 Million in Venture Financing 11
LensAR Raises US$10 Million In Venture Financing 12
LensAR Raises US$17.4 Million In Venture Financing 13
LensAR Raises US$5 Million In Venture Financing 14
LensAR Raises US$24 Million In Series F Financing Round 15
LensAR Secures US$1.4 Million In Venture Financing 16
LensAR Secures US$5 Million In Venture Financing 17
LensAR Secures US$2 Million In Financing Round 18
LensAR Completes US$27 Million In Private Equity Financing 19
Alphaeon Acquires LENSAR for USD59 Million 20
Topcon Europe Medical Invests US$4 Million In LensAR 21
Lensar Inc, Key Competitors 22
Lensar Inc, Key Employees 23

★海外企業調査レポート[Lensar Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daicel Corporation (4202):企業の財務・戦略的SWOT分析
    Daicel Corporation (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Air New Zealand Limited:企業の戦略・SWOT・財務情報
    Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • RedHill Biopharma Ltd (RDHL):製薬・医療:M&Aディール及び事業提携情報
    Summary RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company’s commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Relea …
  • BioCryst Pharmaceuticals Inc (BCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrat …
  • ENGlobal Corp (ENG):石油・ガス:M&Aディール及び事業提携情報
    Summary ENGlobal Corp (ENGlobal) is a specialty engineering services firm that offers oilfield automation solutions. The firm’s services comprise automation integration, engineering and construction, subsea controls and integration, and automation engineering and design services. Its automation inte …
  • Saipem SpA (SPM)-石油・ガス分野:企業M&A・提携分析
    Summary Saipem SpA (Saipem) is an engineering, procurement, construction (EPC) contractor. It provides integrated basic design, Pre-front end engineering design (FEED), FEED and detailed EPC and project management services for complex offshore and onshore projects in the oil and gas industry. The co …
  • Repros Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Porto Seguro SA:企業の戦略・SWOT・財務分析
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Swisscom, Ltd.:企業のM&A・事業提携・投資動向
    Swisscom, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swisscom, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Intercept Pharmaceuticals Inc (ICPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Enzo Clinical Labs Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc, is a medical laboratory that provides testing services. The company develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets, among others. It provides …
  • Sapporo Holdings Ltd (2501):企業の財務・戦略的SWOT分析
    Sapporo Holdings Ltd (2501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Standard Chartered Bank – India Branches:企業の戦略・SWOT・財務情報
    Standard Chartered Bank – India Branches - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Bank – India Branches - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Wellcome Trust Sanger Institute-医療機器分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Chemetall GmbH:企業の戦略的SWOT分析
    Chemetall GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bank Frick & Co. AG:企業の戦略・SWOT・財務情報
    Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Keyence Corporation:企業の戦略・SWOT・財務情報
    Keyence Corporation - Strategy, SWOT and Corporate Finance Report Summary Keyence Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆